Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceutical ...
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1135
https://www.valueinhealthjournal.com/article/S1098-3015(14)03065-4/fulltext
Section Title :
Health Care Use and Policy Studies
Section Order :
635
First Page :
A437
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03065-4&doi=10.1016/j.jval.2014.08.1135